Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Neurotez signs contract with Paragon Bioservices
Neurotez has developed two Leptin products for the treatment of Alzheimer’s disease and other cognitive disorders for which the contract aims at manufacturing of one of the product.
Neurotez has developed two Leptin products for the treatment of Alzheimer’s disease and other cognitive disorders for which the contract aims at manufacturing of one of the product.
Component is investigating the efficacy of vidofludimus in RA with methotrexate, compared to methotrexate alone. In the rial, a total of 244 RA patients were recruited for this
Under the agreement, EpiTherapeutics will receive an upfront payment as well as funding of research activities. In addition, under certain conditions, EpiTherapeutics is eligible to receive milestone payments
Novartis said that the investment is part of an overall $500m commitment in local infrastructure and collaborative healthcare initiatives planned over a five-year period. The partnership addresses three
Letendre will be responsible for spearheading the clinical, regulatory, IP and strategic direction of the company. Based on data from a pilot proof of concept (POC) study in
Superabsorbent polymers are plastics with the capacity to absorb up to 500 times their own weight in liquid. Superabsorbent polymers are mainly used to make diapers. Adult incontinence
Shionogi Pharma and CIMA LABS filed the lawsuit in the US District Court for the District of Delaware. The product is the generic version of Orapred ODT, a
Under the alliance agreement Sanofi-aventis obtains a worldwide exclusive license to develop and commercialize the compounds As part of the research alliance, Sanofi-aventis will work together with Avila
The development candidate, RXI-109, is a self-delivering RNAi compound (sd-rxRNA) that will initially be evaluated for the reduction of dermal scarring in planned surgeries. RXi Pharma said that
The local distributors will sell the China-Biotics’ retail probiotics products through their distribution networks including malls, supermarkets and functional food stores adding approximately 30 new points of sale.